The IDO Battle Gets Ugly Post author:Sam Post published:October 24, 2017 Post category:BioPharma Incyte has been at the forefront of the IDO race with its candidate epacadostat. Source: BioSpace You Might Also Like Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018 Antibe Therapeutics Announces Closing Of Public Offering June 20, 2017 Mesa Labs Declares Quarterly Dividend October 2, 2017
Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018
